Xencor | 销售和管理费用



Selling And Administration Expenses 更改 日
AbbVie USD 3.25B 40M 2025-06
Alnylam Pharmaceuticals USD 323.31M 83.36M 2025-06
Amgen USD 1.69B 4M 2025-06
Arrowhead Research USD 30.95M 3.06M 2025-06
AstraZeneca USD 5.01B 1.42B 2025-06
Biogen USD 583.8M 11.3M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Cytokinetics USD 65.72M 8.35M 2025-06
GlaxoSmithKline GBP 2.14B 80M 2025-06
J&J USD 5.89B 777M 2025-06
MacroGenics USD 27.81M 13.71M 2024-12
Merck USD 2.63B 104M 2025-06
Novartis USD 3.44B 384M 2025-06
Pfizer USD 3.42B 406M 2025-06
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Roche Holding CHF 3.61B 381M 2024-12
Xencor USD 15.11M 2.22M 2025-06


Xencor 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Aug 2025.